Literature DB >> 1558785

Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha.

H Lahm1, L Suardet, P L Laurent, J R Fischer, A Ceyhan, J C Givel, N Odartchenko.   

Abstract

We have tested growth factor responsiveness of a panel of eight human colorectal carcinoma cell lines. Insulin-like growth factors I and II (IGF-I and IGF-II) stimulated growth of five lines (HT-29, LS411N, LS513, SW480, WiDr). At 30 ng ml-1 both factors enhanced growth up to 3-fold. They induced half-maximal stimulation at 1.9-6.51 ng ml-1. Even after delayed addition IGF-I and II significantly enhanced growth in a short-term proliferation assay. They exerted maximal effects under limiting serum conditions (0.5% FCS) and at low cell density (1.25-5 x 10(4) ml-1). Using these conditions transforming growth factor alpha (TGF alpha) enhanced proliferation of all IGF-responsive cell lines, except SW480. 1.11-3.31 ng ml-1 were required to obtain a half-maximal response. With 10-20 ng ml-1 maximal stimulation occurred at plateau values different from those for IGF-I/II. Proliferation of all cell lines responsive to both IGF-I and TGF alpha was further enhanced by combining both factors, resulting a synergistic response of LS513, while the effects on HT-29, LS411N and WiDr were additive. With HT-29 and LS411N a 24 h exposure to TGF alpha was sufficient to obtain a full response in the co-stimulatory assay. Our results illustrate the importance of IGF-I/II and TGF alpha as stimulators of growth of colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558785      PMCID: PMC1977598          DOI: 10.1038/bjc.1992.69

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Integrin-receptor-mediated differentiation and growth inhibition are enhanced by transforming growth factor-beta in colorectal tumour cells grown in collagen gel.

Authors:  M Pignatelli; W F Bodmer
Journal:  Int J Cancer       Date:  1989-09-15       Impact factor: 7.396

Review 2.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

3.  Growth factor production by human colon carcinoma cell lines.

Authors:  M A Anzano; D Rieman; W Prichett; D F Bowen-Pope; R Greig
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

4.  Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.

Authors:  K M Mulder; M K Ramey; N M Hoosein; A E Levine; X H Hinshaw; D E Brattain; M G Brattain
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

5.  Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18.

Authors:  K Tanaka; M Oshimura; R Kikuchi; M Seki; T Hayashi; M Miyaki
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

6.  Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells.

Authors:  G D Shipley; C B Childs; M E Volkenant; H L Moses
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

8.  Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.

Authors:  N M Hoosein; D E Brattain; M K McKnight; A E Levine; M G Brattain
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

9.  Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.

Authors:  G Scala; G Morrone; M Tamburrini; F Alfinito; C I Pastore; G D'Alessio; S Venuta
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

10.  A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.

Authors:  P R Twentyman; M Luscombe
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

View more
  29 in total

Review 1.  Insulin-like growth factors in the gastrointestinal tract and liver.

Authors:  John F Kuemmerle
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-15       Impact factor: 4.741

Review 2.  Regulation of insulin-like growth factors by antiestrogen.

Authors:  R Winston; P C Kao; D T Kiang
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis.

Authors:  Theodoros Rokkas; Dimitrios Pistiolas; Panos Sechopoulos; Georgios Margantinis; Georgios Koukoulis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

4.  Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers.

Authors:  Yu Wang; Yasushi Adachi; Arisa Imsumran; Hiroyuki Yamamoto; Wenhua Piao; Hua Li; Masanori Ii; Yoshiaki Arimura; Mi Young Park; Dalrae Kim; Choon-Taek Lee; David P Carbone; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2009-11-10       Impact factor: 7.527

5.  IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer.

Authors:  Gerrit Peters; Silvia Gongoll; Cord Langner; Michael Mengel; Pompiliu Piso; Jürgen Klempnauer; Josef Rüschoff; Hans Kreipe; Reinhard von Wasielewski
Journal:  Virchows Arch       Date:  2003-07-05       Impact factor: 4.064

6.  Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.

Authors:  B Schnyder; H Lahm; G Woerly; N Odartchenko; B Ryffel; B D Car
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

7.  Progastrin-induced secretion of insulin-like growth factor 2 from colonic myofibroblasts stimulates colonic epithelial proliferation in mice.

Authors:  Carrie A Duckworth; Daniel Clyde; Daniel L Worthley; Timothy C Wang; Andrea Varro; D Mark Pritchard
Journal:  Gastroenterology       Date:  2013-03-19       Impact factor: 22.682

8.  Colonic polyps of acromegalic patients are not associated with mutations of the peroxisome proliferator activated receptor gamma gene.

Authors:  F Bogazzi; F Ultimieri; F Raggi; D Russo; S Brogioni; C Cosci; M Gasperi; A Costa; P Viacava; F Mosca; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

Review 9.  The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines.

Authors:  K Lois; J Bukowczan; P Perros; S Jones; M Gunn; R A James
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

Review 10.  Mechanisms involved in the metastasis of cancer to bone.

Authors:  F W Orr; P Kostenuik; O H Sanchez-Sweatman; G Singh
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.